trial · primary record
Antigen-specific T cells CART/CTL and DCvac
B-Cell Acute Lymphoblastic Leukemia
| Phase | Phase 1 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Safety of infusion |
| Registry ID | NCT05262673 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:06.054Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05262673
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Antigen-specific T cells CART/CTL and DCvac · compound